SK Inc. 034730
KRX · South Korea · Finance
KRW 587,000.00-1,000.00 (-0.17%)
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
RANCHO CORDOVA, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a comprehensive five-year, more than $200 million investment plan to expand and upgrade its U.S. development and manufacturing infrastructure across small molecules and peptides. The strategic initiative is a cornerstone of the company's broader global strategy to secure a resilient supply chain and support the unprecedented demands of its broad customer base. This continues SK pharmteco’s global growth strat
Solidigm IPO Buzz Sends SK Hynix Stock Tumbling
SK Hynix Inc. shares fell as media reports of a potential listing of the chipmaker’s US subsidiary added to concerns over its complex ownership structure.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.